| Role of cytokines and inflammation in heart function during health and disease |
32 |
| Diabetic cardiomyopathy: molecular mechanisms, detrimental effects of conventional treatment, and beneficial effects of natural therapy |
22 |
| Role of microRNAs in doxorubicin-induced cardiotoxicity: an overview of preclinical models and cancer patients |
21 |
| Direct cardiovascular impact of SGLT2 inhibitors: mechanisms and effects |
18 |
| Systematic review of economic burden of heart failure |
14 |
| Biomarkers for the identification of cardiac fibroblast and myofibroblast cells |
14 |
| The heart failure burden of type 2 diabetes mellitus-a review of pathophysiology and interventions |
13 |
| Right ventricular mechanical pattern in health and disease: beyond longitudinal shortening |
12 |
| Effects of exercise training on cardiac function, exercise capacity, and quality of life in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials |
11 |
| Biomarkers in heart failure: the past, current and future |
10 |
| Pathophysiological and therapeutic implications in patients with atrial fibrillation and heart failure |
10 |
| Exercise therapy and autonomic function in heart failure patients: a systematic review and meta-analysis |
10 |
| Metabolic remodeling of substrate utilization during heart failure progression |
9 |
| Diagnostic and prognostic role of cardiac magnetic resonance in acute myocarditis |
9 |
| SGLT2 inhibition and heart failure-current concepts |
9 |
| Pharmacological treatments for heart failure with preserved ejection fraction-a systematic review and indirect comparison |
9 |
| Sex differences in anthracycline-induced cardiotoxicity: the benefits of estrogens |
8 |
| Curcumin as a potential modulator of M1 and M2 macrophages: new insights in atherosclerosis therapy |
8 |
| In search of a standard when analyzing medication adherence in patients with heart failure using claims data: a systematic review |
8 |
| Protective molecular mechanisms of clusterin against apoptosis in cardiomyocytes |
8 |
| Induction immunosuppressive therapy in cardiac transplantation: a systematic review and meta-analysis |
8 |
| Anti-apoptosis in nonmyocytes and pro-autophagy in cardiomyocytes: two strategies against postinfarction heart failure through regulation of cell death/degeneration |
8 |
| Involvement of cytosolic and mitochondrial iron in iron overload cardiomyopathy: an update |
8 |
| Intercalated discs: cellular adhesion and signaling in heart health and diseases |
7 |
| Loop diuretics in chronic heart failure: how to manage congestion? |
7 |
| Primary graft dysfunction after heart transplantation: a thorn amongst the roses |
7 |
| Malignancies and outcome in Takotsubo syndrome: a meta-analysis study on cancer and stress cardiomyopathy |
7 |
| Obesity and heart failure with preserved ejection fraction: a paradox or something else? |
7 |
| Structural and functional abnormalities in iron-depleted heart |
7 |
| Hyperglycemia-induced cardiac contractile dysfunction in the diabetic heart |
7 |
| The left atrium and the right ventricle: two supporting chambers to the failing left ventricle |
6 |
| The relevance of microRNA in post-infarction left ventricular remodelling and heart failure |
6 |
| Hypertrophic cardiomyopathy: an updated review on diagnosis, prognosis, and treatment |
6 |
| Wnt/-catenin in ischemic myocardium: interactions and signaling pathways as a therapeutic target |
6 |
| Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical impact, and management |
6 |
| Redefining biomarkers in heart failure |
6 |
| The role of arterial hypertension in development heart failure with preserved ejection fraction: just a risk factor or something more? |
6 |
| Prognostic value of T1 mapping and extracellular volume fraction in cardiovascular disease: a systematic review and meta-analysis |
6 |
| Flow-mediated dilation and heart failure: a review with implications to physical rehabilitation |
6 |
| The effect of influenza vaccination on mortality and hospitalization in patients with heart failure: a systematic review and meta-analysis |
6 |
| Cardio-oncology: a new and developing sector of research and therapy in the field of cardiology |
5 |
| Continuous versus intermittent administration of furosemide in acute decompensated heart failure: a systematic review and meta-analysis |
5 |
| Cell-based therapies for the treatment of myocardial infarction: lessons from cardiac regeneration and repair mechanisms in non-human vertebrates |
5 |
| Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement |
5 |
| Current animal models for the study of congestion in heart failure: an overview |
5 |
| Immunomodulatory treatment for lymphocytic myocarditis-a systematic review and meta-analysis |
5 |
| Possible mechanisms of direct cardiovascular impact of GLP-1 agonists and DPP4 inhibitors |
5 |
| Imaging technologies for cardiac fiber and heart failure: a review |
5 |
| Sudden death in heart failure with preserved ejection fraction and beyond: an elusive target |
5 |
| Clinical significance of nutritional status in patients with chronic heart failure-a systematic review |
5 |
